Novo Nordisk A/S ADR buy Cantor Fitzgerald
Start price
01.12.23
/
50%
€93.20
Target price
01.12.24
€110.39
Performance (%)
33.71%
Price
27.05.24
€124.00
Summary
This prediction is currently active. With a performance of 33.71% the BUY prediction by Cantor_Fitzgerald is a big success. A total of €0.61 was paid as dividends for this prediction. This prediction currently runs until 01.12.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Novo Nordisk A/S ADR | 0.813% | 0.813% |
iShares Core DAX® | 0.192% | 3.121% |
iShares Nasdaq 100 | 1.245% | 5.051% |
iShares Nikkei 225® | -0.992% | 1.101% |
iShares S&P 500 | 0.154% | 2.864% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $120.00 price target on the stock.
Ratings data for NVO provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€120.00
01.04.24
01.04.24
€148.38
01.04.25
01.04.25
3.33%
27.05.24
27.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€121.00
20.03.24
20.03.24
€147.49
20.03.25
20.03.25
2.99%
27.05.24
27.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€112.50
20.02.24
20.02.24
€129.46
20.02.25
20.02.25
10.77%
27.05.24
27.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€114.00
14.02.24
14.02.24
€130.44
14.02.25
14.02.25
9.31%
27.05.24
27.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€106.50
01.02.24
01.02.24
€128.80
01.02.25
01.02.25
17.01%
27.05.24
27.05.24